Profil

Jaspart Séverine

See author's contact details
Main Referenced Co-authors
Evrard, Brigitte  (13)
Delattre, Luc  (11)
Piel, Géraldine  (7)
Bertholet, Pascal (5)
Bodson, Cédric (3)
Main Referenced Keywords
Administration pulmonaire (1); central composite design (1); Experimental design (1); experimental design (1); Libération prolongée (1);
Main Referenced Disciplines
Pharmacy, pharmacology & toxicology (14)
Veterinary medicine & animal health (1)

Publications (total 15)

The most downloaded
11 downloads
Dehousse, V., Garbacki, N., Jaspart, S., Castagne, D., Piel, G., Colige, A., & Evrard, B. (2010). Comparison of chitosan/siRNA and trimethylchitosan/siRNA complexes behaviour in vitro. International Journal of Biological Macromolecules, 46, 342-349. doi:10.1016/j.ijbiomac.2010.01.010 https://hdl.handle.net/2268/41479

The most cited

155 citations (Scopus®)

Jaspart, S., Piel, G., Delattre, L., & Evrard, B. (January 2005). Solid Lipid Microparticles: Formulation, Preparation, Characterisation, Drug Release and Applications. Expert Opinion on Drug Delivery, 2 (1), 75-87. doi:10.1517/17425247.2.1.75 https://hdl.handle.net/2268/41101

Dehousse, V., Garbacki, N., Jaspart, S., Castagne, D., Piel, G., Colige, A., & Evrard, B. (2010). Comparison of chitosan/siRNA and trimethylchitosan/siRNA complexes behaviour in vitro. International Journal of Biological Macromolecules, 46, 342-349. doi:10.1016/j.ijbiomac.2010.01.010
Peer Reviewed verified by ORBi

Brion, M., Jaspart, S., Perrone, L., Piel, G., & Evrard, B. (November 2009). The supercritical micronization of solid dispersions by Particles from Gas Saturated Solutions using experimental design. Journal of Supercritical Fluids, 51 (1), 50-56. doi:10.1016/j.supflu.2009.06.021
Peer Reviewed verified by ORBi

Nizet, D., Jaspart, S., Brion, M., Lecomte, F., & Evrard, B. (2008). Use of supercritical fluids technology (PGSS) for the production of betametazone loaded solid lipid microparticles [Poster presentation]. 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Barcelona, Spain.

Jaspart, S. (2007). Mise au point et évaluation des microparticules lipidiques solides en vue du développement galénique de préparations pour inhalation à libération prolongée [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315236

Jaspart, S., Bertholet, P., Piel, G., Dogné, J.-M., Delattre, L., & Evrard, B. (January 2007). Solid lipid microparticles as a sustained release system for pulmonary drug delivery. European Journal of Pharmaceutics and Biopharmaceutics, 65 (1), 47-56. doi:10.1016/j.ejpb.2006.07.006
Peer Reviewed verified by ORBi

Jaspart, S., Delattre, L., & Evrard, B. (2007). Formulation and in vitro evaluation of inhalable dry powders containing solid lipid nanoparticles [Poster presentation]. Innovation in drug delivery: from biomaterials to devices, Naples, Italy.

Nizet, D., Jaspart, S., Brion, M., Piel, G., Delattre, L., & Evrard, B. (2007). Supercritical fluid technology to produce solid lipid microparticles [Paper presentation]. XIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.

Tursilli, R., Scalia, S., Piel, G., Jaspart, S., & Delattre, L. (2006). Encapsulation of the sunscreen agent, octyl dimethyl PABA, in lipid microparticles: effect on photostability [Poster presentation]. Skin and Formulation, 2nd Symposium, Versailles, France.

Kirschvink, N, Leemans, J., Delvaux, F., Snaps, F., Jaspart, S., Evrard, B., Delattre, L., Cambier, C., Clercx, C., & Gustin, P. (2006). Inhaled fluticasone reduces bronchial responsiveness and airway inflammation in cats with mild chronic bronchitis. Journal of Feline Medicine and Surgery, 8 (1), 45-54. doi:10.1016/j.jfms.2005.07.001
Peer Reviewed verified by ORBi

Bertholet, P., Jaspart, S., Bodson, C., Piette, M., Piel, G., Delattre, L., & Evrard, B. (June 2005). The effect of cyclodextrins on the aqueous solubility of a new MMP inhihbitor: phase solubility, 1H-NMR spectroscopy and molecular modelling studies, preparation and stability study of nebulizable solutions [Poster presentation]. 1st Pharmaceutical Sciences Fair and Exhibition (PharmSciFair), Nice, France.

Jaspart, S., Piel, G., Delattre, L., & Evrard, B. (January 2005). Solid Lipid Microparticles: Formulation, Preparation, Characterisation, Drug Release and Applications. Expert Opinion on Drug Delivery, 2 (1), 75-87. doi:10.1517/17425247.2.1.75
Peer Reviewed verified by ORBi

Jaspart, S., Bodson, C., Bertholet, P., Delattre, L., & Evrard, B. (2005). In vitro release of salbutamol acetonide from solid lipid nanoparticles. In Proceedings of 1st Pharmaceutical Sciences Fair and Exhibition.
Peer reviewed

Jaspart, S., Bertholet, P., Delattre, L., & Evrard, B. (2005). Study of solid lipid micriparticles as sustained release delivery system for pulmonary administration [Paper presentation]. 15th International symposium on microencapsulation, Parma, Italy.

Jaspart, S., Kirschvink, N., Chiap, P., Delattre, L., Crommen, J., Gustin, P., & Evrard, B. (2004). Solid lipid Nanoparticles for administration by inhalation : Optimisation of manufacturing parameters and preliminary tolerance study [Paper presentation]. 12eme Forum des Sciences Pharmaceutiques, Blankenberge, Belgium.

Jaspart, S., Bodson, C., Bertholet, P., Chiap, P., Delattre, L., & Evrard, B. (2004). Solid lipid Nanoparticles for administration by inhalation : Optimisation of manufacturing parameters [Paper presentation]. European Conference on Drug Delivery and Pharmaceutical Technology, Sevilla, Spain.

Contact ORBi